...
首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Acupuncture for the alleviation of hot flashes in men treated with androgen ablation therapy.
【24h】

Acupuncture for the alleviation of hot flashes in men treated with androgen ablation therapy.

机译:针刺可减轻男性雄激素消融治疗的潮热。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: Hot flashes are common side effect due to androgen ablation therapy (AAT). The utility of acupuncture for hot flashes in men has not been thoroughly studied. We prospectively studied the effect of acupuncture in men with hot flashes. METHODS AND MATERIALS: The study was approved by internal review board. Seventeen men with hot flashes and history of AAT for prostate cancer were enrolled. Three men declined participation before receiving any treatment. A hot flash score (HFS) was used to measure daily hot flashes. The composite daily score was calculated as the product of frequency x severity. The baseline daily scores were compared with scores taken at 2 and 6 weeks and at 8-month average follow-up. RESULTS: No side effects were encountered during, immediately after treatment, or at 8 months. The mean initial HFS was 28.3; it dropped to 10.3 (p = 0.0001) at 2 weeks posttreatment, 7.5 (p = 0.0001) at 6 weeks, and 7.0 (p = 0.001) at 8 months. Clinical improvement for each patient is defined as the percent decrease in the mean HFS at each time point. The mean improvement at Weeks 2 and 6 was 68.4% (mean HFS decreased from 37.409 to 11.836, p = 0.001) and 89.2% (mean HFS decreased from 37.409 to 4.05, p = 0.0078) respectively. The improvement at 8 months was 80.3% (mean HFS decreased from 37.409 to 7.385, p = 0.002). CONCLUSIONS: Acupuncture provides excellent control of hot flashes in men with a history of AAT. The absence of side effects and the durable response at 8 months are likely to be appealing to patients. Prospective randomized study is warranted to further evaluate this modality against medical therapy.
机译:目的:潮红是雄激素消融治疗(AAT)的常见副作用。针灸治疗男性潮热的效用尚未得到充分研究。我们前瞻性地研究了针灸对潮热男性的影响。方法和材料:该研究得到内部审查委员会的批准。入选了十七名潮热和有AAT的前列腺癌病史的男性。三名男子拒绝接受任何治疗前的参与。潮热分数(HFS)用于测量每日潮热。综合每日得分计算为频率x严重程度的乘积。将基线每日得分与第2周和第6周以及平均8个月的平均随访得分进行比较。结果:在治疗过程中,治疗后立即或在8个月时未见副作用。平均初始HFS为28.3;在治疗后2周时下降到10.3(p = 0.0001),在6周时下降到7.5(p = 0.0001),而在8个月时下降到7.0(p = 0.001)。每个患者的临床改善定义为每个时间点平均HFS降低的百分比。第2周和第6周的平均改善分别为68.4%(平均HFS从37.409降低至11.836,p = 0.001)和89.2%(平均HFS从37.409降低至4.05,p = 0.0078)。 8个月时改善率为80.3%(平均HFS从37.409降低至7.385,p = 0.002)。结论:针刺可以很好地控制有AAT病史的男性潮热。无副作用和8个月的持久反应可能对患者有吸引力。必须进行前瞻性随机研究,以进一步评估这种治疗方法对药物治疗的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号